Medtronic PLC Files 8-K: Director Changes and Officer Compensation

Ticker: MDT · Form: 8-K · Filed: 2025-01-21T00:00:00.000Z

Sentiment: neutral

Topics: governance, officer-compensation, board-changes

Related Tickers: MDT

TL;DR

Medtronic's board is shuffling, new director elected, exec pay details filed.

AI Summary

On January 17, 2025, Medtronic plc filed an 8-K report detailing the departure of a director and the election of a new director. The filing also disclosed compensatory arrangements for certain officers. Specific details regarding the individuals involved or the financial terms of the compensatory arrangements were not provided in this excerpt.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance matters like director changes and compensation disclosures, which typically carry low immediate risk.

Key Players & Entities

FAQ

Who is the departing director and who is the newly elected director?

The filing does not specify the names of the departing or newly elected directors.

What are the details of the compensatory arrangements for certain officers?

The filing indicates that compensatory arrangements for certain officers are disclosed, but the specific details are not provided in this excerpt.

What is the effective date of the changes reported in the 8-K?

The effective date of the changes reported in the 8-K is January 17, 2025.

What specific items are covered under the 'ITEM INFORMATION' section of this filing?

The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers, as well as financial statements and exhibits.

What is Medtronic's fiscal year end?

Medtronic's fiscal year end is April 25 (0425).

From the Filing

0001613103-25-000005.txt : 20250121 0001613103-25-000005.hdr.sgml : 20250121 20250121065155 ACCESSION NUMBER: 0001613103-25-000005 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250117 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250121 DATE AS OF CHANGE: 20250121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0425 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 25540394 BUSINESS ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: BUILDING TWO PARKMORE BUSINESS PARK WEST CITY: GALWAY STATE: L2 ZIP: 1 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20250117.htm 8-K mdt-20250117 0001613103 H91 VY19 false 0001613103 2025-01-17 2025-01-17 0001613103 us-gaap:CommonStockMember 2025-01-17 2025-01-17 0001613103 mdt:A0.250SeniorNotesDue2025Member 2025-01-17 2025-01-17 0001613103 mdt:A0.000SeniorNotesDue2025Member 2025-01-17 2025-01-17 0001613103 mdt:A2.625SeniorNotesDue2025Member 2025-01-17 2025-01-17 0001613103 mdt:A1.125SeniorNotesDue2027Member 2025-01-17 2025-01-17 0001613103 mdt:A0.375SeniorNotesDue2028Member 2025-01-17 2025-01-17 0001613103 mdt:A3.000SeniorNotesDue2028Member 2025-01-17 2025-01-17 0001613103 mdt:A3.650SeniorNotesDue2029Member 2025-01-17 2025-01-17 0001613103 mdt:A1.625SeniorNotesDue2031Member 2025-01-17 2025-01-17 0001613103 mdt:A1.000SeniorNotesDue2031Member 2025-01-17 2025-01-17 0001613103 mdt:A3.125SeniorNotesDue2031Member 2025-01-17 2025-01-17 0001613103 mdt:A0.750SeniorNotesDue2032Member 2025-01-17 2025-01-17 0001613103 mdt:A3.375SeniorNotesDue2034Member 2025-01-17 2025-01-17 0001613103 mdt:A3.875SeniorNotesDue2036Member 2025-01-17 2025-01-17 0001613103 mdt:A2.250SeniorNotesDue2039Member 2025-01-17 2025-01-17 0001613103 mdt:A1.500SeniorNotesDue2039Member 2025-01-17 2025-01-17 0001613103 mdt:A1.375SeniorNotesDue2040Member 2025-01-17 2025-01-17 0001613103 mdt:A4.150SeniorNotesDue2043Member 2025-01-17 2025-01-17 0001613103 mdt:A1.750SeniorNotesDue2049Member 2025-01-17 2025-01-17 0001613103 mdt:A1.625SeniorNotesDue2050Member 2025-01-17 2025-01-17 0001613103 mdt:A4.150SeniorNotesDue2053Member 2025-01-17 2025-01-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2025   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) Building Two Parkmore Business Park West Galway , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pur

View on Read The Filing